Xingyu Liu

2.5k total citations
129 papers, 1.7k citations indexed

About

Xingyu Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xingyu Liu has authored 129 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 32 papers in Pulmonary and Respiratory Medicine and 28 papers in Oncology. Recurrent topics in Xingyu Liu's work include Ferroptosis and cancer prognosis (14 papers), RNA modifications and cancer (13 papers) and Cancer-related molecular mechanisms research (11 papers). Xingyu Liu is often cited by papers focused on Ferroptosis and cancer prognosis (14 papers), RNA modifications and cancer (13 papers) and Cancer-related molecular mechanisms research (11 papers). Xingyu Liu collaborates with scholars based in China, United States and Australia. Xingyu Liu's co-authors include Yingying Xu, Zhi‐Feng Miao, Zhenning Wang, Huimian Xu, Tingting Zhao, Hao Xu, Yongxi Song, Jian Wu, Shixuan Wang and Jinjin Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Xingyu Liu

118 papers receiving 1.6k citations

Peers

Xingyu Liu
Yuan Yuan China
Bin Liang China
Tonghui Ma China
Yuanyuan Lei China
Yun‐Ling Zheng United States
Yijun Qi China
Yuan Yuan China
Xingyu Liu
Citations per year, relative to Xingyu Liu Xingyu Liu (= 1×) peers Yuan Yuan

Countries citing papers authored by Xingyu Liu

Since Specialization
Citations

This map shows the geographic impact of Xingyu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyu Liu more than expected).

Fields of papers citing papers by Xingyu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyu Liu. The network helps show where Xingyu Liu may publish in the future.

Co-authorship network of co-authors of Xingyu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyu Liu. A scholar is included among the top collaborators of Xingyu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyu Liu. Xingyu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Wei, Xingyu Liu, Yuanyuan Li, et al.. (2025). Bioorthogonal RNase L Recruitment Enables Targeted Inducible Degradation of SARS‐CoV‐2 RNA. Angewandte Chemie International Edition. 64(51). e202515064–e202515064.
2.
Shen, Wei, et al.. (2025). Strategic base modifications refine RNA function and reduce CRISPR–Cas9 off-targets. Nucleic Acids Research. 53(4). 3 indexed citations
3.
Liu, Weifeng, Guogang Li, Zhenzhen Gao, et al.. (2024). Autologous liver transplantation for unresectable hepatobiliary malignancies in enhanced recovery after surgery model. Open Medicine. 19(1). 20240926–20240926.
4.
Xing, Jing, Ke Wang, Qiuxia Yu, et al.. (2024). Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies. Autoimmunity Reviews. 23(6). 103578–103578. 14 indexed citations
5.
Cao, Yuyang, Shilong Yang, Yuting Liu, et al.. (2024). Controllably hydrolytic dehydrogenation of NH3BH3 over micropore-dominant porous carbon confined RuPd ultrafine alloys. Fuel. 378. 132922–132922. 3 indexed citations
6.
Liu, Xingyu, Ruyuan Li, Shixuan Wang, & Jinjin Zhang. (2024). Global, regional, and national burden of premenstrual syndrome, 1990–2019: an analysis based on the Global Burden of Disease Study 2019. Human Reproduction. 39(6). 1303–1315. 7 indexed citations
7.
Liu, Xingyu, Qianqian Qi, Wei Xiong, et al.. (2024). Unveiling a Potent Small Molecule Disruptor for RNA G-Quadruplexes Tougher Than DNA G-Quadruplex Disruption. ACS Chemical Biology. 19(9). 2032–2040. 3 indexed citations
8.
Qi, Qianqian, Xingyu Liu, Wei Xiong, et al.. (2024). Reducing CRISPR-Cas9 off-target effects by optically controlled chemical modifications of guide RNA. Cell chemical biology. 31(10). 1839–1851.e8. 10 indexed citations
9.
Liu, Xingyu, et al.. (2023). Cis-Regulatory Elements in Mammals. International Journal of Molecular Sciences. 25(1). 343–343. 4 indexed citations
10.
Liu, Xingyu, Jiali Li, Zihang Zeng, et al.. (2023). Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis. Frontiers in Genetics. 14. 1032683–1032683. 3 indexed citations
11.
12.
Sun, Xue, et al.. (2023). Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing. Methods in molecular biology. 2695. 27–46. 1 indexed citations
13.
Fan, Zhiwen, Ming Kong, Wenhui Dong, et al.. (2022). Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration. Cell Death and Disease. 13(5). 495–495. 25 indexed citations
14.
Xiong, Wei, Xingyu Liu, Qianqian Qi, et al.. (2022). Supramolecular CRISPR-OFF switches with host–guest chemistry. Nucleic Acids Research. 50(3). 1241–1255. 12 indexed citations
15.
Liu, Xingyu, Wei Xiong, Huimin Ji, et al.. (2022). A chemical CRISPR off switch efficiently controls gene editing. Cell Reports Physical Science. 3(7). 100956–100956. 9 indexed citations
16.
Liu, Xingyu, Wei Xiong, Qianqian Qi, et al.. (2022). Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing. Nucleic Acids Research. 50(8). 4769–4783. 12 indexed citations
17.
Liu, Xingyu, Qianqian Qi, Yutong Zhang, et al.. (2022). G-quadruplex-guided RNA engineering to modulate CRISPR-based genomic regulation. Nucleic Acids Research. 50(19). 11387–11400. 19 indexed citations
18.
Liu, Xingyu, Qiuji Wu, Xueping Jiang, et al.. (2021). Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma. Cell Transplantation. 30. 4211112902–4211112902. 4 indexed citations
19.
20.
Xie, Lu, Jie Xu, Xin Sun, et al.. (2020). <p>Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study</p>. Cancer Management and Research. Volume 12. 3513–3525. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan Yuan Breakdown of academic impact, for papers by Bin Liang Breakdown of academic impact, for papers by Tonghui Ma Breakdown of academic impact, for papers by Yuanyuan Lei Breakdown of academic impact, for papers by Yun‐Ling Zheng Breakdown of academic impact, for papers by Yijun Qi
Rankless by CCL
2026